دورية أكاديمية
Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD.
العنوان: | Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD. |
---|---|
المؤلفون: | Alqarni AA; Department of Respiratory Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.; Respiratory Therapy Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia., Aldhahir AM; Respiratory Therapy Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia., Alghamdi SA; Respiratory Care Department, Al Murjan Hospital, Jeddah, Saudi Arabia., Alqahtani JS; Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia., Siraj RA; Department of Respiratory Care, College of Applied Medical Sciences, King Faisal University, Al Ahsa, Saudi Arabia., Alwafi H; Faculty of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia., AlGarni AA; King Abdulaziz Hospital, The Ministry of National Guard Health Affairs, Al Ahsa, Saudi Arabia.; King Saud bin Abdulaziz University for Health Sciences, College of Applied Medical Sciences, Al Ahsa, Saudi Arabia., Majrshi MS; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom., Alshehri SM; Department of Respiratory Therapy, King Fahad General Hospital, Jeddah, Saudi Arabia., Pang L; Respiratory Medicine Research Group, Academic Unit for Translational Medical Sciences, University of Nottingham School of Medicine, Nottingham, United Kingdom. |
المصدر: | Frontiers in medicine [Front Med (Lausanne)] 2023 Oct 10; Vol. 10, pp. 1275684. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023). |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Lausanne, Switzerland : Frontiers Media S.A., [2014]- |
مستخلص: | Pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 PH, with no current proven targeted therapies. Studies suggest that cigarette smoke, the most risk factor for COPD can cause vascular remodelling and eventually PH as a result of dysfunction and proliferation of pulmonary artery smooth muscle cells (PASMCs) and pulmonary artery endothelial cells (PAECs). In addition, hypoxia is a known driver of pulmonary vascular remodelling in COPD, and it is also thought that the presence of hypoxia in patients with COPD may further exaggerate cigarette smoke-induced vascular remodelling; however, the underlying cause is not fully understood. Three main pathways (prostanoids, nitric oxide and endothelin) are currently used as a therapeutic target for the treatment of patients with different groups of PH. However, drugs targeting these three pathways are not approved for patients with COPD-associated PH due to lack of evidence. Thus, this review aims to shed light on the role of impaired prostanoids, nitric oxide and endothelin pathways in cigarette smoke- and hypoxia-induced pulmonary vascular remodelling and also discusses the potential of using these pathways as therapeutic target for patients with PH secondary to COPD. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Alqarni, Aldhahir, Alghamdi, Alqahtani, Siraj, Alwafi, AlGarni, Majrshi, Alshehri and Pang.) |
References: | N Engl J Med. 1992 Jul 9;327(2):70-5. (PMID: 1603138) Mol Cell Biochem. 2010 Jan;333(1-2):191-201. (PMID: 19618122) J Am Coll Cardiol. 2003 Apr 16;41(8):1380-6. (PMID: 12706935) Eur Respir J. 2007 Aug;30(2):364-72. (PMID: 17666559) Cell Tissue Res. 2017 Mar;367(3):643-649. (PMID: 28025704) PLoS One. 2014 Jun 06;9(6):e98532. (PMID: 24906007) Am J Physiol. 1995 Aug;269(2 Pt 1):L215-20. (PMID: 7653583) Circulation. 2013 Jan 15;127(2):233-43. (PMID: 23204105) Am J Physiol Lung Cell Mol Physiol. 2009 Apr;296(4):L648-56. (PMID: 19201816) J Appl Physiol (1985). 2006 Feb;100(2):672-8. (PMID: 16210440) Arch Immunol Ther Exp (Warsz). 2015 Feb;63(1):41-52. (PMID: 25288367) Biochem Biophys Res Commun. 2005 Dec 9;338(1):45-52. (PMID: 16115610) Ann Intern Med. 2005 Aug 16;143(4):282-92. (PMID: 16103472) Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4. (PMID: 11897647) Nature. 1976 Jun 17;261(5561):558-60. (PMID: 934294) Chin Med J (Engl). 2010 Dec;123(24):3663-70. (PMID: 22166648) Cardiovasc Res. 2004 Feb 1;61(2):227-37. (PMID: 14736539) Pulm Med. 2012;2012:203952. (PMID: 22973510) J Tongji Med Univ. 1989;9(3):148-52. (PMID: 2513417) Am J Physiol Lung Cell Mol Physiol. 2001 Aug;281(2):L403-11. (PMID: 11435215) N Engl J Med. 2021 Jan 28;384(4):325-334. (PMID: 33440084) Am J Respir Crit Care Med. 2002 Aug 1;166(3):314-22. (PMID: 12153963) J Cell Mol Med. 2012 Aug;16(8):1840-55. (PMID: 22050691) N Engl J Med. 1993 Jun 17;328(24):1732-9. (PMID: 8497283) J Biol Chem. 2003 Sep 26;278(39):37937-47. (PMID: 12835322) Am Rev Respir Dis. 1983 Oct;128(4):702-7. (PMID: 6625346) Am J Respir Crit Care Med. 2004 Nov 15;170(10):1101-7. (PMID: 15317671) J Biol Chem. 1997 Jan 3;272(1):601-8. (PMID: 8995303) J Heart Lung Transplant. 2021 Sep;40(9):1009-1018. (PMID: 34218966) Eur Respir J. 2011 Sep;38(3):617-27. (PMID: 21310874) Naunyn Schmiedebergs Arch Pharmacol. 2008 Sep;378(3):241-51. (PMID: 18542928) Science. 1976 Sep 17;193(4258):1135-7. (PMID: 959827) J Clin Invest. 1999 Jun;103(11):1509-15. (PMID: 10359560) Int J Mol Sci. 2018 Aug 12;19(8):. (PMID: 30103548) Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L548-54. (PMID: 17526595) Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. (PMID: 25830527) Curr Opin Pulm Med. 2023 Sep 1;29(5):370-379. (PMID: 37395513) Respir Res. 2022 May 28;23(1):136. (PMID: 35643499) Lancet. 2008 Jun 21;371(9630):2093-100. (PMID: 18572079) Am J Respir Crit Care Med. 2001 Aug 15;164(4):709-13. (PMID: 11520741) Mol Biol Rep. 2012 Dec;39(12):10447-57. (PMID: 23053949) Am J Physiol. 1998 Jun;274(6):L908-13. (PMID: 9609729) Eur Respir J. 2015 Aug;46(2):346-54. (PMID: 25929951) Eur Respir J. 2016 Oct;48(4):1137-1149. (PMID: 27471204) Lung. 1992;170(2):109-24. (PMID: 1501507) Eur Respir J. 2008 Nov;32(5):1371-85. (PMID: 18978137) Eur Heart J. 2016 Jan 1;37(1):67-119. (PMID: 26320113) Circ J. 2010 May;74(5):836-43. (PMID: 20424334) N Engl J Med. 1972 Apr 27;286(17):912-8. (PMID: 5013974) Eur Respir J. 2003 May;21(5):892-905. (PMID: 12765440) Am J Respir Crit Care Med. 2010 Feb 1;181(3):270-8. (PMID: 19875684) Am J Respir Crit Care Med. 1997 Dec;156(6):1794-9. (PMID: 9412557) Mol Cell Biochem. 2000 May;208(1-2):53-62. (PMID: 10939628) Cardiovasc Res. 1999 Aug 15;43(3):580-94. (PMID: 10690330) Vet Immunol Immunopathol. 2017 Oct;192:33-40. (PMID: 29042013) J Heart Lung Transplant. 2010 Feb;29(2):137-49. (PMID: 20022264) N Engl J Med. 1995 Jul 27;333(4):214-21. (PMID: 7540722) Am J Physiol. 1996 May;270(5 Pt 1):L872-8. (PMID: 8967523) Cardiovasc Res. 2010 Feb 1;85(3):582-92. (PMID: 19710084) Saudi Med J. 2016 May;37(5):498-505. (PMID: 27146611) J Am Coll Cardiol. 2002 May 1;39(9):1496-502. (PMID: 11985913) Eurasian J Med. 2020 Jun;52(2):166-170. (PMID: 32612425) Annu Rev Biochem. 2000;69:145-82. (PMID: 10966456) Cancer Res. 1996 Oct 1;56(19):4424-9. (PMID: 8813136) Eur Respir J. 2002 Apr;19(4):632-8. (PMID: 11998991) Eur Respir J. 2008 Sep;32(3):619-28. (PMID: 18448495) Circulation. 2003 Jul 1;107(25):3230-5. (PMID: 12796132) Herz. 1992 Oct;17(5):291-9. (PMID: 1335437) Eur Respir J. 2002 Aug;20(2):332-8. (PMID: 12212964) Expert Rev Respir Med. 2021 Jan;15(1):51-58. (PMID: 33191816) Front Med (Lausanne). 2023 Aug 29;10:1217156. (PMID: 37706024) Lancet. 2001 Oct 6;358(9288):1119-23. (PMID: 11597664) Crit Care. 2001 Dec;5(6):286-9. (PMID: 11737906) Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):10-3. (PMID: 21801847) Medicina (Kaunas). 2023 Jan 13;59(1):. (PMID: 36676790) Hypertension. 2018 Jan;71(1):34-55. (PMID: 29158355) Am J Kidney Dis. 2020 Jun;75(6):935-945. (PMID: 32199709) Circulation. 2002 Jul 2;106(1):57-62. (PMID: 12093770) Tex Heart Inst J. 2010;37(4):391-9. (PMID: 20844610) ERJ Open Res. 2022 Feb 21;8(1):. (PMID: 35198628) Am J Transl Res. 2017 Sep 15;9(9):3967-3976. (PMID: 28979673) Eur Respir Rev. 2015 Dec;24(138):630-41. (PMID: 26621977) Vasc Health Risk Manag. 2007;3(1):11-22. (PMID: 17583171) Mol Pharmacol. 1995 Nov;48(5):890-6. (PMID: 7476920) Can J Physiol Pharmacol. 2008 Aug;86(8):516-25. (PMID: 18758499) Eur Respir J. 2008 Apr;31(4):891-901. (PMID: 18378784) Respirology. 2008 Nov;13(7):1014-21. (PMID: 18699805) Curr Drug Targets. 2011 Apr;12(4):501-13. (PMID: 21194405) Front Pharmacol. 2019 Jan 18;9:1518. (PMID: 30713496) Circulation. 2014 Dec 9;130(24):2189-208. (PMID: 25602947) J Thorac Dis. 2017 Jan;9(1):30-41. (PMID: 28203404) Contemp Clin Trials. 2011 Mar;32(2):280-7. (PMID: 21146637) Eur Respir J. 2023 Jan 6;61(1):. (PMID: 36028254) Am J Respir Crit Care Med. 2005 Jul 15;172(2):189-94. (PMID: 15831842) Circulation. 2001 Jul 24;104(4):424-8. (PMID: 11468204) Am J Respir Cell Mol Biol. 2012 Apr;46(4):431-6. (PMID: 22033266) Drugs. 2009 Jun 18;69(9):1153-71. (PMID: 19537834) J Immunol. 2010 Jan 1;184(1):433-41. (PMID: 20028661) Heart Vessels. 2018 Nov;33(11):1411-1422. (PMID: 29796776) Int J Chron Obstruct Pulmon Dis. 2018 Apr 13;13:1177-1186. (PMID: 29695901) Am J Physiol Lung Cell Mol Physiol. 2002 Oct;283(4):L717-25. (PMID: 12225948) N Engl J Med. 2002 Mar 21;346(12):896-903. (PMID: 11907289) J Biol Chem. 1998 Aug 21;273(34):22120-7. (PMID: 9705357) Thorax. 2005 Jul;60(7):605-9. (PMID: 15994270) Life Sci. 2012 Oct 15;91(13-14):607-12. (PMID: 22406300) Nature. 1988 Mar 31;332(6163):411-5. (PMID: 2451132) Eur Respir J. 2012 Oct;40(4):874-80. (PMID: 22362844) Int J Clin Exp Med. 2009;2(1):87-94. (PMID: 19436835) Oxid Med Cell Longev. 2016;2016:5249086. (PMID: 27594972) Respir Res. 2001;2(2):90-101. (PMID: 11686871) Mayo Clin Proc. 2020 Sep;95(9):1978-1988. (PMID: 32861339) Am Heart J. 2014 Feb;167(2):210-7. (PMID: 24439982) Eur Respir J. 2023 Jul 20;62(1):. (PMID: 37414421) Ther Adv Respir Dis. 2009 Feb;3(1):15-21. (PMID: 19293199) Mol Pharmacol. 2002 Nov;62(5):1147-53. (PMID: 12391278) BMJ. 2020 Feb 19;368:m234. (PMID: 32075787) Respir Res. 2022 Dec 15;23(1):349. (PMID: 36522710) Am J Respir Cell Mol Biol. 2002 Dec;27(6):688-96. (PMID: 12444028) COPD. 2012 Jun;9(3):268-75. (PMID: 22360383) Biochem Biophys Res Commun. 2007 Nov 23;363(3):656-61. (PMID: 17904526) Thorax. 1981 Oct;36(10):752-8. (PMID: 7330793) Am J Respir Crit Care Med. 2007 Apr 1;175(7):676-85. (PMID: 17255567) Int J Chron Obstruct Pulmon Dis. 2016 Jul 05;11:1533-41. (PMID: 27462149) Acta Physiol (Oxf). 2012 Aug;205(4):507-19. (PMID: 22554045) Ann Intern Med. 1991 Mar 15;114(6):464-9. (PMID: 1994793) Am J Respir Cell Mol Biol. 2010 Dec;43(6):629-34. (PMID: 20008280) FASEB J. 2001 Feb;15(2):427-38. (PMID: 11156958) J Clin Invest. 2020 Nov 2;130(11):5638-5651. (PMID: 32881714) Cardiovasc Res. 2018 Mar 15;114(4):529-539. (PMID: 29394331) J Appl Physiol (1985). 1994 May;76(5):1976-82. (PMID: 8063659) Respir Res. 2007 Nov 01;8:77. (PMID: 17974037) Pathol Res Pract. 2020 Sep;216(9):153083. (PMID: 32825951) Am J Respir Crit Care Med. 2002 Feb 1;165(3):398-405. (PMID: 11818328) Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011. (PMID: 29746142) Core Evid. 2007 Nov 30;2(2):131-50. (PMID: 21221181) Biomedicines. 2021 Jan 09;9(1):. (PMID: 33435311) Respir Investig. 2019 Jul;57(4):325-329. (PMID: 31085118) Pharmacol Rev. 2012 Jul;64(3):540-82. (PMID: 22679221) FASEB J. 2005 Jul;19(9):1178-80. (PMID: 15897232) Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40. (PMID: 12480614) Prostaglandins Other Lipid Mediat. 2018 Jan;134:32-37. (PMID: 29180071) Eur Respir J. 2006 Mar;27(3):578-84. (PMID: 16507859) Eur Heart J. 2022 Oct 11;43(38):3618-3731. (PMID: 36017548) Eur Respir Rev. 2014 Sep;23(133):350-5. (PMID: 25176971) Br J Pharmacol. 2010 Dec;161(7):1599-615. (PMID: 20698855) J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):56S-61S. (PMID: 15194179) Eur Respir J. 2019 Jun 27;53(6):. (PMID: 30956210) Am J Physiol. 1998 Apr;274(4):L517-26. (PMID: 9575869) Eur Respir J. 2013 Oct;42(4):982-92. (PMID: 23429918) J Biol Chem. 2000 May 19;275(20):15314-20. (PMID: 10809766) Chest. 2005 May;127(5):1531-6. (PMID: 15888824) J Biol Chem. 2004 Dec 17;279(51):53036-47. (PMID: 15471868) J Lipid Res. 2011 Apr;52(4):720-31. (PMID: 21296955) Adv Exp Med Biol. 2021;1303:209-241. (PMID: 33788196) Pulm Circ. 2012 Apr-Jun;2(2):193-200. (PMID: 22837860) Proc Am Thorac Soc. 2005;2(4):258-66; discussion 290-1. (PMID: 16267346) J Cardiovasc Pharmacol Ther. 2021 Sep;26(5):453-462. (PMID: 33836637) Eur J Pharmacol. 2013 Mar 5;703(1-3):11-7. (PMID: 23399768) J Appl Physiol (1985). 2005 Mar;98(3):1111-8; discussion 1091. (PMID: 15516370) J Clin Invest. 1994 Feb;93(2):493-8. (PMID: 8113389) Eur Respir J. 2017 Jul 20;50(1):. (PMID: 28729479) Cardiovasc Res. 2001 Jan;49(1):200-6. (PMID: 11121812) Eur Respir J. 2008 Apr;31(4):759-64. (PMID: 18094009) J Healthc Eng. 2022 Feb 10;2022:3247807. (PMID: 35186226) N Engl J Med. 2002 Aug 1;347(5):322-9. (PMID: 12151469) Int J Chron Obstruct Pulmon Dis. 2020 Jun 09;15:1315-1324. (PMID: 32606641) Am Rev Respir Dis. 1993 Aug;148(2):310-6. (PMID: 8342892) J Vasc Res. 2011;48(6):465-75. (PMID: 21691120) Pulm Circ. 2013 Jan;3(1):20-30. (PMID: 23662172) Dev Biol. 2018 Dec 1;444 Suppl 1:S156-S169. (PMID: 30171849) Am Rev Respir Dis. 1984 Dec;130(6):993-8. (PMID: 6439091) Br J Pharmacol. 2021 Jan;178(1):132-151. (PMID: 31976545) J Clin Invest. 1993 Apr;91(4):1367-73. (PMID: 7682570) Sci Rep. 2015 Nov 27;5:17376. (PMID: 26611322) Respiration. 1991;58(5-6):304-10. (PMID: 1792422) Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1877-85. (PMID: 17541026) Eur Respir J. 2012 Apr;39(4):927-38. (PMID: 21828025) |
فهرسة مساهمة: | Keywords: COPD; COPD-associated pulmonary hypertension; endothelin; nitric oxide; prostanoid; pulmonary hypertension; pulmonary hypertension in COPD; type 3 pulmonary hypertension |
تواريخ الأحداث: | Date Created: 20231026 Latest Revision: 20231027 |
رمز التحديث: | 20231027 |
مُعرف محوري في PubMed: | PMC10597708 |
DOI: | 10.3389/fmed.2023.1275684 |
PMID: | 37881627 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2296-858X |
---|---|
DOI: | 10.3389/fmed.2023.1275684 |